ID
39730
Beschreibung
Phase 3 Study of BI 207127 in Combination With Faldaprevir and Ribavirin for Treatment of Patients With Hepatitis C Infection, Including Patients Who Are Not Eligible to Receive Peginterferon: HCVerso2; ODM derived from: https://clinicaltrials.gov/show/NCT01728324
Link
https://clinicaltrials.gov/show/NCT01728324
Stichworte
Versionen (1)
- 14.02.20 14.02.20 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
14. Februar 2020
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Hepatitis C, Chronic NCT01728324
Eligibility Hepatitis C, Chronic NCT01728324
- StudyEvent: Eligibility
Beschreibung
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschreibung
Hepatitis C Genotype Mixed | Hepatitis virus genotyping
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0019196
- UMLS CUI [1,2]
- C1533728
- UMLS CUI [1,3]
- C0205430
- UMLS CUI [2]
- C2368162
Beschreibung
Hepatitis C Genotype | Hepatitis C Genotype Mixed | Hepatitis C Genotype undefined
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0019196
- UMLS CUI [1,2]
- C1533728
- UMLS CUI [2,1]
- C0019196
- UMLS CUI [2,2]
- C1533728
- UMLS CUI [2,3]
- C0205430
- UMLS CUI [3,1]
- C0019196
- UMLS CUI [3,2]
- C1533728
- UMLS CUI [3,3]
- C0750600
Beschreibung
Liver disease | Etiology Except Chronic Hepatitis C
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0023895
- UMLS CUI [2,1]
- C0015127
- UMLS CUI [2,2]
- C0332300
- UMLS CUI [2,3]
- C0524910
Beschreibung
HIV Infection
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0019693
Beschreibung
Hepatitis B | Hepatitis B Surface Antigens Present
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0019163
- UMLS CUI [2,1]
- C0019168
- UMLS CUI [2,2]
- C0150312
Beschreibung
Malignant Neoplasms | Malignant Neoplasm Suspected
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0006826
- UMLS CUI [2,1]
- C0006826
- UMLS CUI [2,2]
- C0750491
Beschreibung
DRUG ABUSE ILLICIT | Exception Marihuana | Alcoholic Intoxication, Chronic
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0743253
- UMLS CUI [2,1]
- C1705847
- UMLS CUI [2,2]
- C0024808
- UMLS CUI [3]
- C0001973
Beschreibung
Compliance Unwilling Precautionary procedure | Precautionary procedure Preventing Photosensitivity
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C1321605
- UMLS CUI [1,2]
- C0558080
- UMLS CUI [1,3]
- C1300317
- UMLS CUI [2,1]
- C1300317
- UMLS CUI [2,2]
- C1292733
- UMLS CUI [2,3]
- C0349506
Beschreibung
Decompensated liver disease
Datentyp
boolean
Alias
- UMLS CUI [1]
- C4075847
Beschreibung
Cardiovascular Disease Unstable
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0007222
- UMLS CUI [1,2]
- C0443343
Beschreibung
Disease Erythrocytic
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0012634
- UMLS CUI [1,2]
- C0014792
Beschreibung
Body Weight
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0005910
Ähnliche Modelle
Eligibility Hepatitis C, Chronic NCT01728324
- StudyEvent: Eligibility
C0166049 (UMLS CUI [2,1])
C1514241 (UMLS CUI [2,2])
C0369335 (UMLS CUI [3,1])
C0442726 (UMLS CUI [3,2])
C1533728 (UMLS CUI [1,2])
C2368162 (UMLS CUI [2])
C0332197 (UMLS CUI [1,2])
C0019196 (UMLS CUI [1,3])
C1533728 (UMLS CUI [1,2])
C0205430 (UMLS CUI [1,3])
C2368162 (UMLS CUI [2])
C1533728 (UMLS CUI [1,2])
C0019196 (UMLS CUI [2,1])
C1533728 (UMLS CUI [2,2])
C0205430 (UMLS CUI [2,3])
C0019196 (UMLS CUI [3,1])
C1533728 (UMLS CUI [3,2])
C0750600 (UMLS CUI [3,3])
C0015127 (UMLS CUI [2,1])
C0332300 (UMLS CUI [2,2])
C0524910 (UMLS CUI [2,3])
C0019168 (UMLS CUI [2,1])
C0150312 (UMLS CUI [2,2])
C0006826 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
C1705847 (UMLS CUI [2,1])
C0024808 (UMLS CUI [2,2])
C0001973 (UMLS CUI [3])
C0558080 (UMLS CUI [1,2])
C1300317 (UMLS CUI [1,3])
C1300317 (UMLS CUI [2,1])
C1292733 (UMLS CUI [2,2])
C0349506 (UMLS CUI [2,3])
C0443343 (UMLS CUI [1,2])
C0014792 (UMLS CUI [1,2])